| [1] |
De Cremoux P，Grandin L，Diéras V，et al.Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients[J].Anticancer Res，2009,29(5):1475-82.
|
| [2] |
Kim TD，Song KS，Li G，et al.Activity and expression of urokinase-type plasminogen activatorand matrix metalloproteinases in human colorectal cancer[J].BMC Cancer,2006,6:211.
|
| [3] |
Usher PA，Thomsen OF，Iversen P，et al.Expression of urokinase plasminogen activator，itsreceptor and type-1 inhibitor in malignant and benign prostate tissue[J].Int J Cancer,2005,113(6):870-80.
|
| [4] |
Huang T,Fu SM,Liang Z,et al.Expression of uPA and uPAR in nasopharyngeal carcinoma and itsclinical significance[J].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,2009,23(11):517-9.[黄涛,符生苗,梁茱,等.鼻咽癌组织中UPA及UPAR蛋白的表达及其临床意义[J].临床耳鼻咽喉头颈外科杂志,2009,23（11）:517-9.]
|
| [5] |
Pakneshan P，Têtu B，Rabbani SA.Demethylation of urokinase promoter as a prognostic marker inpatients with breast carcinoma[J].Clin Cancer Res,2004,10(9):3035-41.
|
| [6] |
Kong WJ，Zhang S，Guo CK，et al.Effect of methylation-associated silencing of thedeathassociated protein kinase gene on nasopharyngeal carcinoma[J].Anticancer Drugs，2006,17(3):251-9.
|
| [7] |
Kong WJ，Zhang S，Guo CK.Methylation-associated silencing of death-associated protein kinasegene in laryngeal squamous cell cancer[J].Laryngoscope,2005,115(8):1395-401.
|
| [8] |
Paredes J，Albergaria A，Oliveira JT，et al.P-cadherin overexpression is an indicator ofclinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation[J].Clin Cancer Res,2005,11(16):5869-77.
|
| [9] |
Nishigaki M，Aoyagi K，Danjoh I,et al.Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays[J].Cancer Res,2005,65(6):2115-24.
|
| [10] |
Szyf M.DNA methylation and demethylation as targets for anticancer therapy[J].Biochemistry(Mosc),2005,70(5):533-49.
|
| [11] |
Gaylis FD，Keer HN，Wilson MJ，et al.Plasminogen activators in human prostate cancer celllines and tumors:correlation with the aggressive phenotype[J].J Urol,1989,142(1):193-8.
|
| [12] |
Minoo P,Baker K，Baumhoer D，et al.Urokinase-type plasminogen activator is a marker ofaggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectalcancer[J].Hum Pathol,2010,41(1):70-8.
|
下载:
